ArticleCancer gene therapy2024

BAG2, MAD2L1, and MDK are cancer-driver genes and candidate targets for novel therapies in malignant pleural mesothelioma.

Luisa Bisceglia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.